Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-23 4:42 pm Sale | 13G | SYNTHETIC BIOLOGICS INC SYN | Iroquois Capital Management LLC | 2,308,696 1.92% | -300,000 (-11.50%) | View |
2022-02-23 4:39 pm Purchase | 13G | OBLONG INC OBLG | Iroquois Capital Management LLC | 1,211,000 3.78% | 631,000 (+108.79%) | View |
2022-02-23 4:36 pm Sale | 13G | ARTELO BIOSCIENCES INC CO ARTL | Iroquois Capital Management LLC | 100,000 0.24% | -820,000 (-89.13%) | View |
2022-02-23 4:29 pm Unchanged | 13G | HOTH THERAPEUTICS INC HOTH | Iroquois Capital Management LLC | 1,265,822 4.99% | 0 (Unchanged) | View |
2022-02-23 4:25 pm Purchase | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management LLC | 1,194,202 4.99% | 469,924 (+64.88%) | View |
2021-11-04 07:38 am Purchase | 13D | PHARMACYTE BIOTECH INC PMCB | Iroquois Capital Management LLC | 1,048,646 5.1% | 1,048,646 (New Position) | View |
2021-10-22 06:51 am Purchase | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management LLC | 724,278 9.99% | 724,278 (New Position) | View |
2021-09-21 4:30 pm Purchase | 13G | CHARLIES HLDGS INC CHUC | Iroquois Capital Management LLC | 14,851,386 6.4% | 14,851,386 (New Position) | View |
2021-03-18 07:03 am Purchase | 13G | HOTH THERAPEUTICS INC HOTH | Iroquois Capital Management LLC | 1,265,822 5.5% | 1,265,822 (New Position) | View |
2021-02-22 10:02 am Sale | 13G | BLUE EARTH, INC. BBLU | Iroquois Capital Management LLC | 125,135 0.87% | -1,206,163 (-90.60%) | View |
2021-02-22 09:56 am Purchase | 13G | MYMD PHARMACEUTICALS INC N MYMD | Iroquois Capital Management LLC | 3,121,620 9.99% | 1,026,072 (+48.96%) | View |
2021-02-22 09:53 am Sale | 13G | AETHLON MED INC PAR $0.001 AEMD | Iroquois Capital Management LLC | 149,170 1.22% | -27,997 (-15.80%) | View |
2021-02-22 09:45 am Unchanged | 13G | SYNTHETIC BIOLOGICS INC SYN | Iroquois Capital Management LLC | 2,608,696 9.99% | 0 (Unchanged) | View |
2021-02-22 09:27 am Sale | 13G | VISLINK TECHNOLOGIES INC N VISL | Iroquois Capital Management LLC | 77,017 0.36% | -5,223,702 (-98.55%) | View |
2021-02-03 07:27 am Purchase | 13G | AYRO INC AYRO | Iroquois Capital Management LLC | 1,666,667 8.3% | 1,666,667 (New Position) | View |
2021-01-04 07:43 am Purchase | 13G | BLUE EARTH, INC. BBLU | Iroquois Capital Management LLC | 1,331,298 7.77% | 1,331,298 (New Position) | View |
2020-12-15 07:31 am Purchase | 13G | OBLONG INC OBLG | Iroquois Capital Management LLC | 580,000 7.6% | 580,000 (New Position) | View |
2020-11-19 08:16 am Purchase | 13G | MYMD PHARMACEUTICALS INC N MYMD | Iroquois Capital Management LLC | 2,095,548 9.99% | 2,095,548 (New Position) | View |
2020-10-19 3:25 pm Purchase | 13G | ARTELO BIOSCIENCES INC CO ARTL | Iroquois Capital Management LLC | 920,000 6.67% | 920,000 (New Position) | View |
2020-02-19 08:27 am Sale | 13G | VISLINK TECHNOLOGIES INC N VISL | Iroquois Capital Management LLC | 5,300,719 9.99% | -2,379,855 (-30.99%) | View |